A real-world safety study found that patients treated with brolucizumab had low occurrences of intraocular inflammation, retinal vascular occlusion, and retinal vasculitis.
Equity, access, and carbon cost-effectiveness of bilateral cataract surgery – Authors' reply thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Each month, our editorial staff compiles a recap of the top news in ophthalmology. Our November 2023 month-in-review features a trio of FDA news, important updates to the GA pipeline, and insight into disparities in eye care.
Most patients with diabetic retinopathy who take the GLP-1 agonist semaglutide don t experience a worsening of the condition, a new study found, but they still require screening and follow-up.